Entrada Therapeutics, Inc.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Entrada Therapeutics, Inc.
RECRUITINGPhase 1 / Phase 2NCT07038824
A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and...
This is a study of the investigational medicine ENTR-601-45 in participants who have Duchenne muscular dystrophy (DMD), a rare genetic condition. The researchers want to: Test how...
Sponsor: Entrada Therapeutics, Inc.Enrolling: 2415 locations
Duchenne Muscular Dystrophy (DMD)
RECRUITINGPhase 1 / Phase 2NCT07037862
A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and...
This is a study of the investigational medicine ENTR-601-44 in participants who have Duchenne muscular dystrophy (DMD), a rare genetic condition. The researchers want to: Test...
Sponsor: Entrada Therapeutics, Inc.Enrolling: 2414 locations
Duchenne Muscular Dystrophy (DMD)